The holidays are fast approaching along with cooler weather and various respiratory illnesses. Here's when to get your ...

On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...

AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...

AstraZeneca’s new U.S. spending also leaves in doubt the pharmaceutical company’s plans to invest in a vaccine site in ...

The company said it aims to expand its U.S. presence by the end of 2026. The new spending will be for a research-and-development center in Cambridge, Mass.; manufacturing plants in Maryland and Texas, ...

The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...

LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...

More than one in two Irish parents say their child missed schools days in the past year due to flu or flu-like symptoms with ...

I t’s not just officially cold and flu season, it’s RSV season. RSV, which stands for respiratory syncytial virus, is a highly contagious illness that affects people of all ag ...

Canada has detected its first presumptive case of H5 bird flu in a person, a teenager in the western province of British ...

Investing.com - Moderna (NASDAQ:MRNA) has reported a shallower-than-anticipated loss in the third quarter and announced changes at its leadership team, as the drugmaker looks to address issues ...

A pioneering DNA test is being rolled out on the NHS as experts say there is a one in four chance of another pandemic on the scale of Covid-19 in the next decade ...